294 related articles for article (PubMed ID: 23555181)
1. Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.
Christiansen VJ; Jackson KW; Lee KN; Downs TD; McKee PA
Neoplasia; 2013 Apr; 15(4):348-58. PubMed ID: 23555181
[TBL] [Abstract][Full Text] [Related]
2. Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase.
Jackson KW; Christiansen VJ; Yadav VR; Silasi-Mansat R; Lupu F; Awasthi V; Zhang RR; McKee PA
Neoplasia; 2015 Jan; 17(1):43-54. PubMed ID: 25622898
[TBL] [Abstract][Full Text] [Related]
3. Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase.
Poplawski SE; Lai JH; Li Y; Jin Z; Liu Y; Wu W; Wu Y; Zhou Y; Sudmeier JL; Sanford DG; Bachovchin WW
J Med Chem; 2013 May; 56(9):3467-77. PubMed ID: 23594271
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies.
Kelly T; Huang Y; Simms AE; Mazur A
Int Rev Cell Mol Biol; 2012; 297():83-116. PubMed ID: 22608558
[TBL] [Abstract][Full Text] [Related]
5. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.
LeBeau AM; Brennen WN; Aggarwal S; Denmeade SR
Mol Cancer Ther; 2009 May; 8(5):1378-86. PubMed ID: 19417147
[TBL] [Abstract][Full Text] [Related]
6. Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy.
Brennen WN; Isaacs JT; Denmeade SR
Mol Cancer Ther; 2012 Feb; 11(2):257-66. PubMed ID: 22323494
[TBL] [Abstract][Full Text] [Related]
7. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.
Brennen WN; Rosen DM; Wang H; Isaacs JT; Denmeade SR
J Natl Cancer Inst; 2012 Sep; 104(17):1320-34. PubMed ID: 22911669
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast activation protein in remodeling tissues.
Jacob M; Chang L; Puré E
Curr Mol Med; 2012 Dec; 12(10):1220-43. PubMed ID: 22834826
[TBL] [Abstract][Full Text] [Related]
9. Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design.
Lee KN; Jackson KW; Terzyan S; Christiansen VJ; McKee PA
Biochemistry; 2009 Jun; 48(23):5149-58. PubMed ID: 19402713
[TBL] [Abstract][Full Text] [Related]
10. Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α.
Plescia J; De Cesco S; Patrascu MB; Kurian J; Di Trani J; Dufresne C; Wahba AS; Janmamode N; Mittermaier AK; Moitessier N
J Med Chem; 2019 Sep; 62(17):7874-7884. PubMed ID: 31393718
[TBL] [Abstract][Full Text] [Related]
11. Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-α for different indications.
Plescia J; Hédou D; Pousse ME; Labarre A; Dufresne C; Mittermaier A; Moitessier N
Eur J Med Chem; 2022 Oct; 240():114543. PubMed ID: 35797897
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α.
Jambunathan K; Watson DS; Endsley AN; Kodukula K; Galande AK
FEBS Lett; 2012 Jul; 586(16):2507-12. PubMed ID: 22750443
[TBL] [Abstract][Full Text] [Related]
13. Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications.
Šimková A; Bušek P; Šedo A; Konvalinka J
Biochim Biophys Acta Proteins Proteom; 2020 Jul; 1868(7):140409. PubMed ID: 32171757
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.
Huang Y; Simms AE; Mazur A; Wang S; León NR; Jones B; Aziz N; Kelly T
Clin Exp Metastasis; 2011 Aug; 28(6):567-79. PubMed ID: 21604185
[TBL] [Abstract][Full Text] [Related]
15. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?
Juillerat-Jeanneret L; Tafelmeyer P; Golshayan D
Expert Opin Ther Targets; 2017 Oct; 21(10):977-991. PubMed ID: 28829211
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein.
Dvořáková P; Bušek P; Knedlík T; Schimer J; Etrych T; Kostka L; Stollinová Šromová L; Šubr V; Šácha P; Šedo A; Konvalinka J
J Med Chem; 2017 Oct; 60(20):8385-8393. PubMed ID: 28953383
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast activation protein: A potential therapeutic target in cancer.
Liu R; Li H; Liu L; Yu J; Ren X
Cancer Biol Ther; 2012 Feb; 13(3):123-9. PubMed ID: 22236832
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
[TBL] [Abstract][Full Text] [Related]
20. The application of the fibroblast activation protein α-targeted immunotherapy strategy.
Jiang GM; Xu W; Du J; Zhang KS; Zhang QG; Wang XW; Liu ZG; Liu SQ; Xie WY; Liu HF; Liu JS; Wu BP
Oncotarget; 2016 May; 7(22):33472-82. PubMed ID: 26985769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
